- Home
- KMDA vs AZUL Comparison
KMDA vs AZUL Comparison
Compare KMDA & AZUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- AZUL
- Stock Information
- Founded
- KMDA 1990
- AZUL 2008
- Country
- KMDA Israel
- AZUL Brazil
- Employees
- KMDA N/A
- AZUL N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- AZUL Air Freight/Delivery Services
- Sector
- KMDA Health Care
- AZUL Consumer Discretionary
- Exchange
- KMDA Nasdaq
- AZUL Nasdaq
- Market Cap
- KMDA 349.6M
- AZUL 337.4M
- IPO Year
- KMDA N/A
- AZUL 2017
- Fundamental
- Price
- KMDA $5.87
- AZUL $1.72
- Analyst Decision
- KMDA Strong Buy
- AZUL Hold
- Analyst Count
- KMDA 2
- AZUL 9
- Target Price
- KMDA $14.50
- AZUL $6.59
- AVG Volume (30 Days)
- KMDA 30.2K
- AZUL 1.6M
- Earning Date
- KMDA 11-13-2024
- AZUL 11-14-2024
- Dividend Yield
- KMDA N/A
- AZUL N/A
- EPS Growth
- KMDA 124.29
- AZUL N/A
- EPS
- KMDA 0.27
- AZUL N/A
- Revenue
- KMDA $158,380,000.00
- AZUL $3,468,415,494.00
- Revenue This Year
- KMDA $15.38
- AZUL N/A
- Revenue Next Year
- KMDA $6.18
- AZUL $14.10
- P/E Ratio
- KMDA $21.16
- AZUL N/A
- Revenue Growth
- KMDA 4.52
- AZUL 4.33
- 52 Week Low
- KMDA $4.74
- AZUL $1.90
- 52 Week High
- KMDA $6.53
- AZUL $10.37
- Technical
- Relative Strength Index (RSI)
- KMDA 52.31
- AZUL 28.43
- Support Level
- KMDA $5.71
- AZUL $2.17
- Resistance Level
- KMDA $5.90
- AZUL $2.30
- Average True Range (ATR)
- KMDA 0.16
- AZUL 0.12
- MACD
- KMDA -0.03
- AZUL -0.03
- Stochastic Oscillator
- KMDA 40.35
- AZUL 2.52
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About AZUL Azul S.A. (each representing three preferred shares)
Azul SA is involved in the operation of regular and non-regular airline passenger services, cargo or mail, passenger charter, provision of maintenance and hangarage services for aircraft, engines, parts and pieces, aircraft acquisition and lease, development of frequent-flyer programs, development of related activities and equity holding in other companies. The Company considers that it has a single reportable segment which is air transport.